Stoke Therapeutics, Inc. STOK
Regular-session close
After hours · Nov 20, 4:34 PM ET
- YTD
- -15.53%
- 1 year
- -4.01%
Held by funds
121 US ETFs and mutual funds hold STOK · largest positions
- VGHCX 0.20% of fund $76.00M
- VTI 0.00% of fund $40.44M
- FBIOX 0.65% of fund $38.75M
- IWM 0.05% of fund $38.39M
- XBI 0.37% of fund $36.08M
- NJM 0.04% of fund $33.99M
- VXF 0.02% of fund $19.37M
- FSSNX 0.06% of fund $18.82M
- FSPHX 0.24% of fund $16.33M
- FIDGX 0.18% of fund $16.25M
- IWO 0.10% of fund $13.81M
- SHSSX 0.19% of fund $12.44M
- NLO 0.08% of fund $11.90M
- IBB 0.10% of fund $11.18M
- SCHA 0.04% of fund $9.06M
- TCAF 0.07% of fund $8.84M
- FHCIX 0.26% of fund $8.58M
- VTWO 0.05% of fund $8.51M
- FBTTX 0.35% of fund $8.26M
- FSMAX 0.02% of fund $7.81M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.71% | 6,347,831 | 170.19M | Sep 29, 2026 |
| RTW Investments LP | 8.60% | 5,623,525 | 150.77M | Sep 29, 2026 |
| FMR, LLC | 7.65% | 5,000,952 | 134.08M | Sep 29, 2026 |
| Wellington Management Group, LLP | 7.16% | 4,681,855 | 125.52M | Sep 29, 2026 |
| Lynx1 Capital Management Lp | 5.96% | 3,896,169 | 104.46M | Sep 29, 2026 |
| Redmile Group, LLC | 5.92% | 3,869,028 | 103.73M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 3.46% | 2,260,550 | 60.61M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.88% | 1,884,647 | 50.53M | Jun 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.28% | 1,490,481 | 39.96M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.18% | 1,426,549 | 38.25M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.01% | 1,311,567 | 35.16M | Sep 29, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.11% | 729,201 | 19.55M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs STOK, and what each was last paid
Ian F. Smith, Chief Executive Officer & DirectorAverage age 57
| Name | Title | Pay | Age |
|---|---|---|---|
| Ian F. Smith | Chief Executive Officer & Director | $1.41M | 60 |
| Jason Hoitt | Chief Patient Officer | $815K | 48 |
| Thomas Edward Leggett | Chief Financial Officer | $804K | 49 |
| Edward Kaye | Advisor & Director | $736K | 77 |
| Barry S. Ticho FACC | Chief Medical Officer | $727K | 66 |
| Adrian R. Krainer | Co-Founder & Independent Director | $45.0K | 67 |
| Thomas McCauley | Chief Scientific Officer | — | 57 |
| Jonathan Allan | Corporate Secretary, Compliance Officer & General Counsel | — | 36 |
| Isabel Aznarez | Co-Founder & CTO | — | 54 |
| Sara Den Besten | Chief People Officer | — | — |
| Susan Willson | Vice President of Corporate Communications | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLAN JONATHAN | General Counsel | Sale | Aug 17, 2026 | 21,225 |
| HOITT JASON | Officer | Sale | Mar 17, 2026 | 10,276 |
| KAYE EDWARD M | Director | Sale | Aug 17, 2026 | 124,557 |
| KRAINER ADRIAN R | Director | Sale | Mar 9, 2026 | 283,302 |
| LEGGETT THOMAS | Chief Financial Officer | Sale | Mar 17, 2026 | 10,172 |
| LEVIN ARTHUR A. | Director | Sale | Mar 12, 2026 | 22,216 |
